Dyngo® 4a highly potent dynamin inhibitor
Be the first to review this product! Submit a review
|
(92 Publications)
- Dynasore (ab120192) analog
- Used to characterize clathrin-dependent vesicle formation and endocytosis
- Proven performance: cited in over 90 publications
- Chemical Structure
Lab
Chemical Structure - Dyngo® 4a highly potent dynamin inhibitor (AB120689)
2D chemical structure image of ab120689, Dyngo® 4a, Novel, highly potentdynamin inhibitor
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Dyngo® 4a highly potent dynamin inhibitor (AB120689)
ab66705 staining PAI1 in HeLa cells treated with dyngo-4a™ (ab120689), by ICC/IF. Increase in PAI1 expression correlates with increased concentration of dyngo-4a™, as described in literature.
The cells were incubated at 37°C for 6h in media containing different concentrations of ab120689 (dyngo-4a™) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab66705 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- FuncS
PubMed
Functional Studies - Dyngo® 4a highly potent dynamin inhibitor (AB120689)
Primary human monocyte-derived macrophages were treated without (Ctrl) and with ab120689 (Dyngo 4A) for 2 h. Effects on α-tubulin and acetylated tubulin (Ac-tubulin) were determined by confocal microscopy.
Credit : Kockx M et al. PLoS One. 2014; 9(10) : e111186. doi : 10.1371/journal.pone.0111186
Kockx M et al. PLoS One. 2014; 9(10): e111186. doi: 10.1371/journal.pone.0111186 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
Product details
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Publications (92)
Recent publications for all applications. Explore the full list and refine your search
PLoS pathogens 21:e1012564 PubMed40067817
2025
Applications
Unspecified application
Species
Unspecified reactive species
eLife 13: PubMed39812558
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed39768130
2025
Applications
Unspecified application
Species
Unspecified reactive species
Alzheimer's & dementia : the journal of the Alzheimer's Association 21:e14418 PubMed39713861
2024
Applications
Unspecified application
Species
Unspecified reactive species
Science advances 10:eadq3539 PubMed39485845
2024
Applications
Unspecified application
Species
Unspecified reactive species
Molecular metabolism 90:102046 PubMed39401613
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Gastrointestinal and liver physiology 327:G267-G283 PubMed38860860
2024
Applications
Unspecified application
Species
Unspecified reactive species
NPJ Parkinson's disease 10:107 PubMed38773105
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109021 PubMed38361629
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of pharmacology and experimental therapeutics 388:506-517 PubMed37442618
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com